“…Known collectively as the ‘tubulinopathies’, this disease spectrum encompasses numerous neurodevelopmental disorders including, microcephaly, lissencephaly, and polymicrogyria, reflecting the large number of tubulin genes expressed during embryonic brain formation (e.g., TUBA1A , TUBB2A , TUBB2B , TUBB3 , TUBB5 ) ( Keays et al, 2007 ; Jaglin et al, 2009 ; Poirier et al, 2010 ; Breuss et al, 2012 ; Cushion et al, 2014 ; Romaniello et al, 2018 ). In addition to cortical malformations, the tubulinopathies also include disorders of ocular motor function (associated with variants in TUBB3 , TUBB2B & TUBA1A ), whispering dysphonia ( TUBB4A ), amyotrophic lateral sclerosis ( TUBA4A ), female meiotic infertility ( TUBB8 ), Leber congenital amaurosis with hearing loss ( TUBB4B ), and macrothrombocytopaenia ( TUBB1 ) ( Kunishima et al, 2009 ; Bahi-Buisson et al, 2014 ; Smith et al, 2014 ; Feng et al, 2016 ; Luscan et al, 2017 ; Strassel et al, 2019 ; Jurgens et al, 2021 ; Kimmerlin et al, 2022 ). Irrespective of the clinical attributes of the disease the tubulinopathies are predominantly due to de novo heterozygous, missense mutations and are predicted to act in a gain-of-function manner in most instances ( Figure 1 ) ( Romaniello et al, 2018 ; Leca et al, 2020 ).…”